Cargando…
Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs
The United States faces dramatically increasing rates of opioid overdose deaths, as well as persistent ongoing problems of undiagnosed HIV and HCV infection. These problems commonly occur together in substance using populations that have limited, if any, access to primary care and other routine heal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572321/ https://www.ncbi.nlm.nih.gov/pubmed/28879174 http://dx.doi.org/10.3389/fpubh.2017.00217 |
_version_ | 1783259502131281920 |
---|---|
author | Aronson, Ian David Bennett, Alexander Marsch, Lisa A. Bania, Theodore C. |
author_facet | Aronson, Ian David Bennett, Alexander Marsch, Lisa A. Bania, Theodore C. |
author_sort | Aronson, Ian David |
collection | PubMed |
description | The United States faces dramatically increasing rates of opioid overdose deaths, as well as persistent ongoing problems of undiagnosed HIV and HCV infection. These problems commonly occur together in substance using populations that have limited, if any, access to primary care and other routine health services. To collectively address all three issues, we developed the Mobile Intervention Kit (MIK), a tablet computer-based intervention designed to provide overdose prevention and response training and to facilitate HIV/HCV testing in community settings. Intervention content was produced in collaboration with experienced street outreach workers who appear onscreen in a series of educational videos. A preliminary pilot test of the MIK in a Bronx, NY street outreach syringe exchange program found the MIK is feasible and highly acceptable to a population of people who inject drugs. Participants accepted HIV and HCV testing post-intervention, as well as naloxone training to reverse overdose events. Pre-post tests also showed significant increases in knowledge of overdose prevention, HIV testing procedures, and asymptomatic HCV infection. Future iterations of the MIK can be optimized for use in community as well as clinical settings nationwide, and perhaps globally, with a focus on underserved urban populations. |
format | Online Article Text |
id | pubmed-5572321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55723212017-09-06 Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs Aronson, Ian David Bennett, Alexander Marsch, Lisa A. Bania, Theodore C. Front Public Health Public Health The United States faces dramatically increasing rates of opioid overdose deaths, as well as persistent ongoing problems of undiagnosed HIV and HCV infection. These problems commonly occur together in substance using populations that have limited, if any, access to primary care and other routine health services. To collectively address all three issues, we developed the Mobile Intervention Kit (MIK), a tablet computer-based intervention designed to provide overdose prevention and response training and to facilitate HIV/HCV testing in community settings. Intervention content was produced in collaboration with experienced street outreach workers who appear onscreen in a series of educational videos. A preliminary pilot test of the MIK in a Bronx, NY street outreach syringe exchange program found the MIK is feasible and highly acceptable to a population of people who inject drugs. Participants accepted HIV and HCV testing post-intervention, as well as naloxone training to reverse overdose events. Pre-post tests also showed significant increases in knowledge of overdose prevention, HIV testing procedures, and asymptomatic HCV infection. Future iterations of the MIK can be optimized for use in community as well as clinical settings nationwide, and perhaps globally, with a focus on underserved urban populations. Frontiers Media S.A. 2017-08-23 /pmc/articles/PMC5572321/ /pubmed/28879174 http://dx.doi.org/10.3389/fpubh.2017.00217 Text en Copyright © 2017 Aronson, Bennett, Marsch and Bania. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Aronson, Ian David Bennett, Alexander Marsch, Lisa A. Bania, Theodore C. Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title | Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title_full | Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title_fullStr | Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title_full_unstemmed | Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title_short | Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs |
title_sort | mobile technology to increase hiv/hcv testing and overdose prevention/response among people who inject drugs |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572321/ https://www.ncbi.nlm.nih.gov/pubmed/28879174 http://dx.doi.org/10.3389/fpubh.2017.00217 |
work_keys_str_mv | AT aronsoniandavid mobiletechnologytoincreasehivhcvtestingandoverdosepreventionresponseamongpeoplewhoinjectdrugs AT bennettalexander mobiletechnologytoincreasehivhcvtestingandoverdosepreventionresponseamongpeoplewhoinjectdrugs AT marschlisaa mobiletechnologytoincreasehivhcvtestingandoverdosepreventionresponseamongpeoplewhoinjectdrugs AT baniatheodorec mobiletechnologytoincreasehivhcvtestingandoverdosepreventionresponseamongpeoplewhoinjectdrugs |